Haowen Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haowen Li has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Chengya Dong
Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsFanhong Kong
Beijing Tiantan Hospital, Beijing, China
2 shared publications- Haoxiao Chang
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publications Jingli Cao
Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsLi Liu
Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsLijun Liu
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102673
Increased serum phenylalanine and tyrosine concentration related to inflammation in patients with primary angiitis of the central nervous system
- 16 June 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102673
Open AccessIncreased serum phenylalanine and tyrosine concentration related to inflammation in patients with primary angiitis of the central nervous system
- Open Access
- 12 June 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 201, 119624
20(S)-hydroxycholesterol, a natural allosteric agonist of Smoothened, exerts neuroprotective effects associated with angiogenesis and vascular plasticity following ischemia
- 12 June 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 201, 119624
Open Access20(S)-hydroxycholesterol, a natural allosteric agonist of Smoothened, exerts neuroprotective effects associated with angiogenesis and vascular plasticity following ischemia
- Open Access
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 20 (1)
Multiple sclerosis and type 1 diabetes: a Mendelian randomization study of European ancestry
Objectives: Observational studies have indicated that type 1 diabetes (T1D) is prevalent in multiple sclerosis (MS), yet the causality remains unclear. The purpose of this study was to assess the causal association between MS and T1D. Methods: We employed a Mendelian randomization method using two samples to research the causal association between MS and T1D. The study primarily utilized the inverse variance weighted (IVW) method, and we use three methods (MR Egger, Weighted median, Weighted mode) for auxiliary analysis. To avoid reverse causality, we employed the Steiger Test method to further examine the screened SNPs. Furthermore, sensitivity analysis was conducted to ensure the robustness of the obtained results. Results: When MS was considered as the exposure variable and T1D as the outcome variable, the results indicated a significant positive correlation (IVW, OR=1.078, 95 % CI: 1.041−1.117; p<0.001). Conversely, when T1D is the exposure in question, the causal relationship with MS remains undetermined. These results were further validated through sensitivity analysis. Conclusions: The MR analysis results indicate that there is a causal relationship between MS and T1D. We provide compelling genetic evidence to support the causal connection between MS and an increased risk of T1D.
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 20 (1)
Open AccessMultiple sclerosis and type 1 diabetes: a Mendelian randomization study of European ancestry
Objectives: Observational studies have indicated that type 1 diabetes (T1D) is prevalent in multiple sclerosis (MS), yet the causality remains unclear. The purpose of this study was to assess the causal association between MS and T1D. Methods: We employed a Mendelian randomization method using two samples to research the causal association between MS and T1D. The study primarily utilized the inverse variance weighted (IVW) method, and we use three methods (MR Egger, Weighted median, Weighted mode) for auxiliary analysis. To avoid reverse causality, we employed the Steiger Test method to further examine the screened SNPs. Furthermore, sensitivity analysis was conducted to ensure the robustness of the obtained results. Results: When MS was considered as the exposure variable and T1D as the outcome variable, the results indicated a significant positive correlation (IVW, OR=1.078, 95 % CI: 1.041−1.117; p<0.001). Conversely, when T1D is the exposure in question, the causal relationship with MS remains undetermined. These results were further validated through sensitivity analysis. Conclusions: The MR analysis results indicate that there is a causal relationship between MS and T1D. We provide compelling genetic evidence to support the causal connection between MS and an increased risk of T1D.
- Open Access
- 22 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 14505
A Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy
Epilepsy is one of the common encephalopathies caused by sudden abnormal discharges of neurons in the brain. About 30% of patients with epilepsy are insensitive and refractory to existing antiseizure medications. The sonic hedgehog signaling pathway is essential to the development and homeostasis of brain. Aberrant sonic hedgehog signaling is increased in refractory epileptic lesions and may involve the etiology of epilepsy. Thus, new inhibitors of Smoothened, a key signal transducer of this signaling pathway are urgently need for refractory epilepsy. We have established a high-throughput screening platform and discovered several active small molecules targeting Smoothened including TT22. Here we show that the novel Smoothened inhibitor TT22 could block the translocation of βarrestin2-GFP to Smoothened, reduce the accumulation of Smoothened on primary cilia, displace Bodipy-cyclopamine binding to Smoothened, and inhibit the expression of downstream Gli transcription factor. Moreover, TT22 inhibits the abnormal seizure-like activity in neurons. Furthermore, we demonstrated that FDA-approved Smoothened inhibitor GDC-0449 and LDE-225 are able to inhibit abnormal seizure-like activity in neurons. Thus, our study suggests that targeting the sonic hedgehog signaling with new small-molecule Smoothened inhibitors might provide a potential new therapeutic avenue for refractory epilepsy.
- 22 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 14505
Open AccessA Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy
Epilepsy is one of the common encephalopathies caused by sudden abnormal discharges of neurons in the brain. About 30% of patients with epilepsy are insensitive and refractory to existing antiseizure medications. The sonic hedgehog signaling pathway is essential to the development and homeostasis of brain. Aberrant sonic hedgehog signaling is increased in refractory epileptic lesions and may involve the etiology of epilepsy. Thus, new inhibitors of Smoothened, a key signal transducer of this signaling pathway are urgently need for refractory epilepsy. We have established a high-throughput screening platform and discovered several active small molecules targeting Smoothened including TT22. Here we show that the novel Smoothened inhibitor TT22 could block the translocation of βarrestin2-GFP to Smoothened, reduce the accumulation of Smoothened on primary cilia, displace Bodipy-cyclopamine binding to Smoothened, and inhibit the expression of downstream Gli transcription factor. Moreover, TT22 inhibits the abnormal seizure-like activity in neurons. Furthermore, we demonstrated that FDA-approved Smoothened inhibitor GDC-0449 and LDE-225 are able to inhibit abnormal seizure-like activity in neurons. Thus, our study suggests that targeting the sonic hedgehog signaling with new small-molecule Smoothened inhibitors might provide a potential new therapeutic avenue for refractory epilepsy.
- Open Access
- 20 December 2017
- Published by PeerJ in PeerJ Preprints
Establishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital
Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.
- 20 December 2017
- Published by PeerJ in PeerJ Preprints
Open AccessEstablishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital
Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.
- Open Access
- 20 December 2017
- Published by PeerJ in PeerJ Preprints
Establishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital
Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.
- 20 December 2017
- Published by PeerJ in PeerJ Preprints
Open AccessEstablishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital
Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.